Simvastatin and clarithromycin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Clarithromycin can increase simvastatin exposure and myopathy risk
Clarithromycin inhibits CYP3A4 and can markedly increase simvastatin concentrations. This increases the risk of myopathy and rhabdomyolysis, so simvastatin should usually be withheld during the macrolide course or an alternative antibiotic considered. Metformin is not the main safety concern in this scenario.
Reference: https://www.pharmacyregulation.org/students-and-trainees/pharmacist-education-and-training/registration-assessment